Forbion European Acquisit... (FRBNU)
NASDAQ: FRBNU
· Real-Time Price · USD
20.00
-0.62 (-3.01%)
At close: Oct 31, 2023, 7:37 PM
Company Description
Forbion European Acquisition Corp. does not have significant operations.
The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities.
It intends to identify opportunities in the life sciences industry in Europe.
The company was incorporated in 2021 and is based in Wilmington, Delaware.
Forbion European Acquisition Corp.
| Country | United States |
| IPO Date | Dec 10, 2021 |
| Industry | Shell Companies |
| Sector | Financial Services |
| Employees | n/a |
| CEO | Dr. Jasper M. Bos Ph.D. |
Contact Details
Address: 4001 Kennett Pike Wilmington, Delaware United States | |
| Website | https://forbion.com/en/feac/ |
Stock Details
| Ticker Symbol | FRBNU |
| Exchange | NASDAQ |
| Fiscal Year | n/a |
| Reporting Currency | USD |
| CIK Code | 0001874495 |
| CUSIP Number | G3619H128 |
| ISIN Number | n/a |
| Employer ID | 00-0000000 |
| SIC Code | 6770 |
Key Executives
| Name | Position |
|---|---|
| Dr. Jasper M. Bos Ph.D. | Chief Executive Officer |
| Cyril Lesser L.L.M., M.Sc., MSc. | Chief Financial Officer & Controller |
| Cyril Lesser MSc. | Chief Financial Officer & Controller |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Feb 14, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Feb 14, 2024 | SC 13G | Statement of acquisition of beneficial ownership b... |
| Feb 08, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Jan 19, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Nov 13, 2023 | 15-12G | Filing |
| Nov 02, 2023 | 8-K | Current Report |
| Nov 01, 2023 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Oct 31, 2023 | 4 | Filing |
| Oct 31, 2023 | 4 | Filing |
| Oct 31, 2023 | 3/A | [Amend] Filing |